关注
Hans Liebisch Rey
Hans Liebisch Rey
在 unisabana.edu.co 的电子邮件经过验证
标题
引用次数
引用次数
年份
Carbapenem therapeutic drug monitoring in critically ill adult patients and clinical outcomes: a systematic review with meta-analysis
S Lechtig-Wasserman, H Liebisch-Rey, N Diaz-Pinilla, J Blanco, ...
Antibiotics 10 (2), 177, 2021
152021
Administration and Therapeutic Drug Monitoring of β-lactams and Vancomycin in Critical Care Units in Colombia: The ANTIBIOCOL Study
YV Fuentes, J Blanco, DM Díaz-Quijano, S Lechtig-Wasserman, ...
Pharmaceutics 13 (10), 1577, 2021
72021
Panorama mundial de las diferentes plataformas de vacunas contra el COVID-19: revisión y reflexión de la literatura actual
H LlEBISCH-REY, J FRANCO BUSTOS, R Salazar-Reggeti, ...
Revista Salud Uninorte 37 (1), 162-188, 2021
32021
Modeling Metabolic Diseases with Organoids: A Review
JF Bustos, JCA Gonzalez, D Angelo, R de Abreu, H Liebisch-Rey, A Silva, ...
J. ISSN 2766, 2276, 2021
32021
The short-term cost-effectiveness of once-weekly semaglutide versus once-weekly dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults
H Liebisch-Rey, AM Suarez-Chacon, YV Fuentes, J Blanco, J Kock, ...
F1000Research 12, 2023
2023
Worldwide Overview of the Different COVID-19 Vaccine Platforms: A Review and Reflection on the Current Evidence
H LlEBISCH-REY, J FRANCO BUSTOS, R SALAZAR-REGGETI, ...
Revista Salud Uninorte 37 (1), 162-188, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–6